4//SEC Filing
LORANGER STEVEN R 4
Accession 0001225208-25-001751
CIK 0001099800other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:41 PM ET
Size
9.3 KB
Accession
0001225208-25-001751
Insider Transaction Report
Form 4
LORANGER STEVEN R
Director
Transactions
- Sale
Common Stock
2025-02-14$76.42/sh−5,739$438,576→ 60,372 total - Exercise/Conversion
Director Stock Option (Right to Acquire)
2025-02-14−5,739→ 0 totalExercise: $45.32From: 2018-05-18Exp: 2025-05-17→ Common Stock (5,739 underlying) - Exercise/Conversion
Common Stock
2025-02-14$45.32/sh+5,739$260,073→ 66,111 total
Holdings
- 15,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $76.400 to $76.435. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001226924
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:41 PM ET
- Size
- 9.3 KB